Latest News
03rdSeptember, 2019
VivaGel® BV regulatory approvals continue in Asia
VivaGel® BV has received a further regulatory approval in Asia Mundipharma will market VivaGel® BV under their brand name BETADINETM BV Gel in Asian countries This additional approval...
15thAugust, 2019
First Asian Regulatory Approvals Received for VivaGel® BV
VivaGel® BV has received regulatory approval in South East Asian countries, with further registration reviews at an advanced stage throughout the region Mundipharma will market VivaGel® BV...
26thJuly, 2019
Novartis, Mundipharma ink partnership to enhance access to three Asian countries to established medicine brands for glau...
Novartis and Mundipharma have signed an agreement for Mundipharma to market, sell and distribute Novartis medicines in the general ophthalmology disease area, including medicines for glaucoma and...
19thJuly, 2019
BETADINE® Celebrates the Golden Jubilee of the First Moon Landing
BETADINE® Celebrates the Golden Jubilee of the First Moon Landing The antiseptic chosen by NASA ensured moon germs were not brought back to earth Singapore, 19 July 2019 – Across the globe,...
01stJuly, 2019
Inaugural Winner of the Mundipharma Cancer Care Challenge Shines at Innovfest Unbound
[caption id="attachment_2856" align="aligncenter" width="480"] The winning team: Low Zi An and Trevor Tan Wei Kiat[/caption] SINGAPORE, 28 June 2019 – The five finalist teams of the inaugural...
13stMay, 2019
Mundipharma Extends Nutraceutical Portfolio with launch of MaxvidaTM in Vietnam
Singapore, Monday 13 May 2019 – Mundipharma has extended its portfolio of nutraceuticals by launching MaxvidaTM – a balanced nutritional supplement with 32 key nutrients – in Vietnam. ...
